Quantcast

Latest AstraZeneca Stories

2014-03-03 00:20:29

BASEL, Switzerland, March 3, 2014 /PRNewswire/ -- -- ELATUS((TM)) fungicide receives regulatory approval in Brazil -- Delivers outstanding control of soybean rust disease -- Higher and more predictable yields for Latin American growers Syngenta today announced that ELATUS, a breakthrough foliar fungicide, has been approved by the Brazilian authorities. ELATUS is a combination of Syngenta's new SDHI chemistry SOLATENOL((TM) )and AMISTAR(®). It offers unrivaled performance...

2014-02-25 20:21:36

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines) has announced the addition of the "H1N1 Vaccines - Global Strategic Business Report" [http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides...

2014-02-20 16:21:25

Agreement with Biopharmaceutical Leader is Indicative of the Longstanding Value of CAS Products COLUMBUS, Ohio, Feb. 20, 2014 /PRNewswire/ -- Chemical Abstracts Service (CAS), the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder(®), the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The...

2014-02-20 12:23:17

- Agrisure Duracade(TM) introductory launch program "Right to Grow" offers farmers step-change in corn rootworm control and 2014 grain marketing options MINNETONKA, Minn., Feb. 20, 2014 /PRNewswire/ -- Syngenta announced today an agreement with Gavilon Grain, LLC that provides grain marketing opportunities for farmers who choose to plant Agrisure Duracade, the cutting-edge corn rootworm (CRW) control technology that has been approved in the U.S. For farmers participating in the...

2014-02-20 08:32:38

COLUMBIA, S.C., Feb. 20, 2014 /PRNewswire/ -- BDI Pharma today announced the launch of The MERREM Commitment Program(TM) with AstraZeneca, an assurance initiative offering customers security in product availability through contracted access to the original, branded MERREM®I.V. from AstraZeneca. Along with this innovative new partnership, BDI Pharma was awarded the status of Authorized Distributor of Record (ADR) for AstraZeneca and is the sole and exclusive distributor of...

2014-02-17 08:25:37

LONDON, Feb. 17, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Developments and Trends in Influenza Therapeutics (Technical Insights) Emerging Technology and Major Partnerships in Influenza Vaccines Influenza is a burgeoning problem across the entire globe, there is an increased need for new therapeutic methods. A whole host of technology platforms are being utilized to create non egg based vaccines. The world has not seen an influenza pandemic, and in...

2014-02-14 00:20:57

BASEL, Switzerland, Feb. 14, 2014 /PRNewswire/ -- Syngenta announced that the 2013 Annual Report on Form 20-F has been filed with the U.S. Securities and Exchange Commission. The document is available on the Syngenta website at www.syngenta.com; hard copies of the audited financial statements are available to shareholders free of charge upon request. Syngenta is one of the world's leading companies with more than 28,000 employees in over 90 countries dedicated to our purpose:...

2014-02-05 20:23:53

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9lglrg/biologics_and) has announced the addition of the "Biologics and Biosimilars World Markets" [http://www.researchandmarkets.com/research/9lglrg/biologics_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics...

2014-02-05 08:30:28

SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- Ambrx Inc. today announced the appointment of Barry Greene to its board of directors. Mr. Greene has more than 20 years of experience in the healthcare, pharmaceutical and biotechnology industries. He is currently president and chief operating officer of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), a leader in RNAi therapeutics. The appointment increases Ambrx's board membership to six. "Barry joins Ambrx's board at a very exciting time for...

2014-02-05 04:20:37

LONDON, February 5, 2014 /PRNewswire/ -- In a full year-results video interview, Syngenta Chief Executive Mike Mack reveals that the company grew integrated sales 6% during 2013. He also announces a major cost efficiency programme: "The cost is $900m and it will deliver benefits of $1bn per year of annualised cost savings... It's going to be targeted in three areas, the first is production, the second is in research and development and thirdly, perhaps most importantly,...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related